Royal Bank Of Canada View Ray, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.35 - $3.28 $92,176 - $863,824	-263,361 Reduced 80.45%	64,002 $22,000
Q1 2023 May 15, 2023	BUY	$3.28 - $4.81 $101,643 - $149,057	30,989 Added 10.46%	327,363 $1.13 Million
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $44,358 - $58,577	12,153 Added 4.28%	296,374 $1.33 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $87,077 - $129,961	-32,736 Reduced 10.33%	284,221 $1.04 Million
Q2 2022 Aug 15, 2022	SELL	$2.42 - $4.05 $93,109 - $155,823	-38,475 Reduced 10.82%	316,957 $840,000
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $314,950 - $532,220	91,290 Added 34.56%	355,432 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $375,214 - $582,388	76,731 Added 40.94%	264,142 $1.46 Million
Q3 2021 Nov 15, 2021	BUY	$5.18 - $7.41 $872,773 - $1.25 Million	168,489 Added 890.44%	187,411 $1.35 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $74,552 - $127,723	18,922 New	18,922 $125,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.